Teamwork combats bleomycin shortage | B.J. Rimel, MD
Two weeks ago my partner, Dr. Andrew Li, operated on a very young woman with a stage IV yolk sac tumor. We had discussed the chemotherapy regimen to give her and discussed the standard treatment of bleomycin, etoposide and cisplatin. Two days later we received and email from our pharmacy: “There is a national supply shortage of bleomycin. There is not enough drug at this hospital to start any new patients on regimens that contain this drug.”
Palliative care in cervical cancer, part II | Lois Ramondetta, MD
The discussion of futility is not new to cervical cancer or to gynecologic oncology, but that doesn’t make it any easier. The goal, in a terminal setting, is always to extend life but not if it means compromising quality of life (QOL). Who is to say that one week more of life–in any condition–is not “quality” to someone else?
Palliative care in cervical cancer, part I | Lois Ramondetta, MD
As Cervical Cancer Awareness Month comes to a close, I find myself more tormented and frustrated about the status of health care in the United States when I see a woman who has been diagnosed with, treated for, or dying from cervical cancer than I do with any other gynecologic cancer. Delivering bad news is never easy, but telling someone that they have cancer is especially difficult when we know it could have been prevented.
Death with Dignity | Michael L. Pearl, MD, FACOG, FACS
Some patients influence our lives in ways we never expect.
In July, 1989, I was a brand new chief resident, learning to manage an extremely busy and complicated gynecologic oncology service. With four active gynecologic oncologists, lengths of stay averaging a week and minimal outpatient chemotherapy, our inpatient census typically numbered in the 20’s.
Medicinal cannabis: The genie is out of the bottle | Christopher Lutman, MD
In 1996, Proposition 215 was passed by the citizens of California, which became the first state to legalize the usage of cannabis for medical purposes. Since that historic ballot measure, medicinal cannabis has now become legal in 23 states. It is also legal in the District of Columbia and the overseas territories of Guam and Puerto Rico.
SGO Annual Meeting: A Latin American perspective | Erick Estrada, MD
Latin America is a region with tremendous potential, diverse cultures and languages, our own unique problems but a very genuine mission to eradicate women´s cancer. The local economy plays an important role in dictating access to health care but we are determined to overcome any barriers, because our mission is based upon knowledge instead of bureaucracy.
#gyncsm – A Growing Community | Dee Sparacio
In September 2013, I wrote about the establishment of the #gyncsm (gynecologic cancer social media) monthly tweet chat. Over the past year, #gyncsm discussed a variety of topics relevant to the gynecologic cancer community. During the hour-long online discussion we asked four to five questions on each month’s topic. At the conclusion of each chat, we posted the questions, a chat transcript and links to the resources mentioned during the chat on our blog (gyncm.blogspot.com).
My Gift of Hope | Linda Ryan
As a three-time cancer survivor, I am more aware of how much meaning my life has now. Not only how precious life is and how thankful I am to be alive, but also of the opportunity to give back.
At the Center of it All | Dee Sparacio
Over the past nine years I have seen an increase in the number of non-profit organizations whose mission is to raise awareness of gynecologic cancers and funds for research. There are national organizations and many local gynecologic cancer organizations that consistently raise awareness about the risks and symptoms of gynecologic cancers via TV, radio, print, Twitter and Facebook. Other non-profits fund research host dinners, walks and runs, teas, and auctions. This private funding has been so important the past few years as government funding of cancer research has been reduced.
SGO Obesity Toolkit can empower patients | Lauren S. Prescott, MD
In 1997, the World Health Organization formally recognized obesity as a global epidemic. Seventeen years later, we are still facing alarming increases in obesity. As a resident in obstetrics and gynecology and now a fellow in gynecologic oncology, I have struggled to adequately address obesity and weight management with many of my patients.